TrumpRx.gov direct-purchase option (Live Now) TrumpRx.gov launched February 6, 2026, offering GLP-1 medications at negotiated prices: Average price: ~$346/month (down from ~$1,086 retail) Who can use it: Anyonenot limited to Medicare/Medicaid Medicare/Medicaid patients: May pay even less once the July 2026 bridge program ($50/mo) begins Best Option for Medicare Patients If you have Medicare and can't wait for mid-2026 Part D coverage, TrumpRx.gov at ~$346/month is available now
Daily Replenisher protocol The Daily Replenisher powder requires more preparation
Although compounded formulations helped fill access gaps during the national GLP-1 shortage, these products remain unapproved and subject to strict regulatory limits
Law enforcement officers managing metabolic health on semaglutide should consult their agency medical review procedures for any prescription medication disclosure requirements that their specific department may have
BPC-157 is an FDA advisory board approved peptide designed to support tissue repair and reduce localized joint inflammation, making it highly effective for osteoarthritis and soft tissue injuries
Schedule A Consultation Contact Us CJC-1295 CJC-1295 also acts on the GHRH pathway, but it promotes longer and more pronounced GH stimulation